Home  >  TopNews
Events + Font Resize -

Industry stalwarts pledge to take India beyond all frontiers in volume of drug production and in value by 2030

Peethaambaran Kunnathoor, Chennai
Tuesday, February 13, 2018, 08:00 Hrs  [IST]

Stalwarts of all segments of the pharmaceutical sector in India have pledged that they will altogether strive to take India beyond all frontiers in the volume of drug production by 2030 and to exceed 130 billion USD in business value.

Further, efforts will be taken to work on innovation to bring in a minimum of ten new drugs through pharmaceutical and biological routes. While concentrating on new innovations, the country needs to retain the leadership in global generics also, they felt. Thirdly, more attention is required in making India’s regulatory practices on par with global standards and ensure our regulatory approval acceptable to all countries in the world.

The committed personalities of the Indian pharmaceutical sector assembled on the platform of the 7th National Convention of the Indian Pharmaceutical Association (IPA) in Chennai last week. The Convention identified five focus areas as strategic pillars to adapt Indian pharmaceutical sector for a world leader in drug production and pharmacy profession in 2030.

The country needs to have industry ready pharmacists with innovative and entrepreneurial skills for the global community. The practice of pharmacy profession also needs changes. From mere selling of medicines, the pharmacists must ‘dispense’ medicines through proper pharmacy practice.

Termed the five strategic pillars as ‘punchfutas’ (five elements) of growth, Dr. B Suresh, president of the Pharmacy Council of India, while delivering his lecture on the overarching theme of the convention, “Pharma Vision 2030- Planning the Future”, said India needs to concentrate on biological route to invent new drugs as in the way pharmaceutical route is focused. More research has to be made on this area and these studies should be incorporated in the syllabus of pharmacy education.

According to him, the segments such as industry, regulatory, education, pharmacy practice and pharma environment are the five strategic pillars the pharmaceutical sector needs to concentrate on for strengthening. Government must provide a conducive atmosphere for all the five pillars of the sector to grow. Dr. Vadlamudi Rao, president of IPA presided over the meeting.

Sharing the dais, SV Veeramani, immediate past president of the IDMA, said the Indian pharma industry is planning to open up new vistas of growth for medical devices and soon foray into investing more on APIs. India needs 100 % self-sufficiency in active pharmaceutical ingredients and should avoid its dependence on other countries for APIs.

T N Sivabalan, director of drugs control department in Tamil Nadu, said all pharmaceutical manufacturers should always make attempt to maintain superior quality in their products. Dr. Bengaru Rajan, deputy director at CDSCO also spoke in the meeting.

Dr.S Manivannan, chairman of the organizing committee of the event welcomed the audience and J Jayaseelan, chairman of TN IPA gave an over-all review about IPA and the national convention.

The event was bigger in its scope and spirit this year as there was increased number of participation from industry, institutions, regulatory side and pharmacy profession.


* Name :     
* Email :    
  Website :  
Copyright © 2016 Saffron Media Pvt. Ltd |